Dec 2, 2025, 09:51
Time to Refocus on NSTEMI․ Why This State-of-the-Art Review Matters
Davide Capodanno, Professor of Cardiology at University of Catania, editor-in-Chief of EuroIntervention, shared on X:
”We always talk about STEMI—and rightly so—but shouldn’t we also focus on NSTEMI? It is no less challenging; in fact, in several respects it is even more complex, as patients are typically older, more often multivessel, and clinically more difficult to manage. This is why this state-of-the-art review on the diagnosis, risk stratification, and early management of non–ST-segment elevation acute coronary syndromes, in my view, deserves careful reading. ”
Find more information here.

Find more posts on Hemostasis Today.
-
Feb 27, 2026, 11:21Amelia Carro Hevia: Effect of Alirocumab on Coronary Plaque After MI
-
Feb 27, 2026, 11:14Dino Mehic: Completing the Missing Puzzle Pieces in VITT Pathogenesis
-
Feb 26, 2026, 15:58Daniel Victor Ortigoza։ Lipoprotein(a) Levels Predict Long-Term Cardiovascular Risk in Women
-
Feb 26, 2026, 15:51Augustina Isioma Ikusemoro: The Real Miracle in Trauma Care Happens Behind the Scenes
-
Feb 26, 2026, 15:42Jim Hoffman։ Targeting NETosis to Improve Perfusion and Reduce Thrombosis in AMI
-
Feb 26, 2026, 15:40Elvira Grandone: ISTH Launches An International Survey to Capture Real-World Practice of Pregnancy Anemia
-
Feb 26, 2026, 15:39Ashok Yadav: Placental Glycogen as a Vital Energy Reserve for Fetal and Placental Health
-
Feb 26, 2026, 15:37Nayab Ahmed: Main Reasons for Washing Platelet-Rich Plasma
-
Feb 26, 2026, 15:36Robert Negrin Shares His Outlook for the Year Ahead as ASH President